全球基因组学市场规模（按技术、应用、产品/服务、地区、范围和预测）

基因体学市场规模及预测

基因组学市场规模预计在 2023 年达到 447.1 亿美元，预计在 2024 年至 2031 年期间的复合年增长率为 18.90%，到 2031 年将达到 1584.5 亿美元。全球基因组学是指对生物体整个基因组成进行全面研究和分析，包括其 DNA 序列、基因功能和相互作用。它在个人化医疗、农业和生物技术等领域中发挥着重要作用。在医疗保健领域，基因组学可以根据个人的基因特征进行精准治疗，改善癌症和遗传性疾病等疾病的治疗效果。在农业领域，基因编辑可以使作物更有弹性、更高产量。

在人工智慧和数据分析创新的推动下，全球基因组学的未来有望推动基因治疗、药物发现和永续农业的进步。

全球基因体学市场动态

主要市场驱动因子

个人化医疗需求不断成长：

个人化医疗的日益普及是一个主要推动因素，个人化医疗是根据个人的基因特征制定治疗方案。根据美国国立卫生研究院的数据，2022 年批准的药物中约有 39% 将是个人化疗法。

基因体定序的技术进步：

下一代定序（NGS）等定序技术的不断创新，大大降低了基因组定序的成本。美国国家人类基因组研究所报告称，到2022年，人类基因组定序成本将从2001年的1亿美元降至1,000美元以下。

政府资助与研究计画：

世界各国政府都在投资基因组研究。例如，美国政府已于2023年为国家人类基因组研究所拨款6亿美元，以支持基因体学研究的进步。

遗传疾病发生率不断上升：

癌症和罕见疾病等遗传疾病和病症的增加推动了对基因组研究的需求。世界卫生组织 (WHO) 估计，大约 10% 的出生受到遗传或部分遗传疾病的影响，这推动了对基因组诊断和治疗的需求。

主要问题

基因组技术成本高：

儘管取得了进展，但全基因组定序和数据分析等先进基因组技术的成本仍然很高，限制了它们的普及，尤其是在中低收入国家。

资料隐私与道德问题：

敏感遗传资讯的储存和分享引发了人们对隐私和滥用的担忧，并存在歧视和未经授权存取个人健康资料的潜在风险。

解释基因组数据的复杂性：

基因组数据庞大且复杂，对准确解释研究结果提出了课题，并且需要先进的计算工具和尚未广泛普及的专业知识。

监管和标准化问题：

全球基因组学市场面临不同地区不同的监管框架，缺乏标准化协议可能会减缓基因组技术在临床和研究环境中的采用。

主要趋势：

整合人工智慧（AI）与机器学习：

人工智慧和机器学习越来越多地被用于分析大量基因组数据，提高准确性并加速疾病诊断和药物开发等领域的发现。

直接面向消费者的基因体学的扩展：

越来越多的上市公司提供直接面向消费者的基因组测试，使个人能够出于健康、家谱和保健目的获取自己的基因信息，从而增加人们对基因组学的兴趣。

扩大精准医疗计画：

政府和医疗保健系统越来越重视精准医疗，它利用基因组学开发针对每个患者的基因特征的个人化治疗，特别是在癌症治疗方面。

CRISPR 与基因编辑的进展：

基因编辑技术，尤其是 CRISPR，透过提供精确修改基因的工具，正在彻底改变基因组学领域，为基因治疗、农业和生物技术开闢新的可能性。

目录

第 1 章 全球基因体学市场简介

• 市场介绍
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章全球基因体学市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第5章 全球基因体学市场（依技术划分）

• 概述 定序技术
• 微阵列分析 PCR 技术
• CRISPR

第6章全球基因体学市场（按应用）

• 概述
• 诊断
• 药物发现与开发
• 研究
• 农业和畜牧业
• 消费者基因组

第7章全球基因体学市场（依产品及服务划分）

• 概述
• 设备和装置
• 消耗品
• 软体与服务

第 8 章全球基因体学市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 9 章全球基因体学市场：竞争格局

• 概述
• 各公司的市占率
• 主要发展策略

第10章 公司简介

• llumina
• Thermo Fisher Scientific
• Agilent Technologies
• , Danaher Corporation（Beckman Coulter）
• PerkinElmer
• QIAGEN
• BGI Group
• Macrogen
• Oxford Nanopore Technologies

第 11 章附录

• 相关研究

Genomics Market Size and Forecast

Genomics Market size was valued at USD 44.71 Billion in 2023 and is projected to reach USD 158.45 Billion by 2031 , growing at a CAGR of 18.90% from 2024 to 2031. Global genomics refers to the comprehensive study and analysis of an organism's entire genetic makeup, including its DNA sequence, gene functions, and interactions. It plays a crucial role in fields such as personalized medicine, agriculture, and biotechnology. In healthcare, genomics enables precision treatments by tailoring therapies to an individual's genetic profile, improving outcomes for diseases like cancer and genetic disorders. In agriculture, it enhances crop resilience and productivity through gene editing.

The future of global genomics promises advancements in gene therapy, drug discovery, and sustainable agriculture, driven by innovations in artificial intelligence and data analytics.

Global Genomics Market Dynamics

The key market dynamics that are shaping the Genomics Market include:

Key Market Drivers:

Rising Demand for Personalized Medicine:

The increasing adoption of personalized medicine, which tailors treatments based on individual genetic profiles, is a major driver. According to the U.S. National Institutes of Health, approximately 39% of medicines approved in 2022 were personalized therapies.

Technological Advancements in Genomic Sequencing:

Continuous innovations in sequencing technologies, such as next-generation sequencing (NGS), have significantly reduced the cost of genome sequencing. The National Human Genome Research Institute reported that the cost of sequencing a human genome dropped from $100 million in 2001 to below $1,000 in 2022.

Government Funding and Research Initiatives:

Governments worldwide are investing in genomic research. For instance, the U.S. government allocated $600 million to the National Human Genome Research Institute in 2023 to support advancements in genomics research.

Increasing Prevalence of Genetic Disorders:

The rise in genetic diseases and disorders, such as cancer and rare diseases, is driving demand for genomic research. The World Health Organization (WHO) states that around 10% of all births are affected by genetic or partially genetic conditions, fueling the need for genomic diagnostics and therapies.

Key Challenges:

High Cost of Genomic Technologies:

Despite advancements, the cost of advanced genomic technologies like whole genome sequencing and data analysis remains high, limiting accessibility, especially in low- and middle-income countries.

Data Privacy and Ethical Concerns:

The storage and sharing of sensitive genetic information raise concerns about privacy and misuse, with potential risks of discrimination or unauthorized access to personal health data.

Complexity of Genomic Data Interpretation:

The sheer volume and complexity of genomic data present challenges in accurately interpreting findings, requiring advanced computational tools and specialized expertise, which are not widely available.

Regulatory and Standardization Issues:

The global genomics market faces varying regulatory frameworks across different regions, and the lack of standardized protocols can delay the adoption of genomic technologies in clinical and research settings.

Key Trends:

Integration of Artificial Intelligence (AI) and Machine Learning:

AI and machine learning are increasingly being used to analyze vast amounts of genomic data, improving accuracy and speeding up discoveries in areas like disease diagnosis and drug development.

Expansion of Direct-to-Consumer Genomics:

The rise of companies offering direct-to-consumer genomic testing has empowered individuals to access their genetic information for health, ancestry, and wellness purposes, driving public interest in genomics.

Growth of Precision Medicine Initiatives:

Governments and healthcare systems are focusing more on precision medicine, using genomics to develop personalized treatments tailored to the genetic profiles of individual patients, especially in cancer care.

CRISPR and Gene Editing Advancements:

Gene editing technologies, especially CRISPR, are transforming the genomics landscape by offering tools to modify genes with precision, opening new possibilities in gene therapy, agriculture, and biotechnology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Genomics Market Regional Analysis

Here is a more detailed regional analysis of the global genomics market:

North America

North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. The United States, in particular, plays a key role in the region's dominance, with the National Institutes of Health (NIH) allocating over $1.2 billion annually to genomics research. The strong presence of major biotechnology companies and well-established genomic databases further boosts the region's leadership. Moreover, favorable regulatory frameworks and government initiatives like the Precision Medicine Initiative have spurred the growth of personalized genomics in healthcare and research.

The region's robust research environment and cutting-edge technology adoption continue to enhance the genomics market's growth. North America's substantial market share is also attributed to increasing investments in genomic data analysis tools, next-generation sequencing (NGS) technologies, and bioinformatics. As genomics plays a critical role in cancer research, genetic testing, and pharmaceutical development, the region is well-positioned to remain a global leader. The rise in genetic disorder cases and the growing use of genomics in drug development further solidify North America's dominance.

Asia Pacific

Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development. Countries like China, Japan, and India are driving this growth, with China alone projected to see a 12.5% annual growth rate in genomics investments by 2026. The rising awareness of genetic testing and precision medicine, along with the increasing prevalence of chronic diseases, is boosting the demand for genomics-based solutions in the region.

Moreover, government-backed genomics programs like China's Precision Medicine Initiative, which has allocated $9 billion for research, are accelerating the development of genomics in healthcare. In India, the government's Genome India Project aims to map the genetic diversity of over 10,000 individuals, further highlighting the region's focus on genomics research. The growing number of collaborations between local research institutions and global biotechnology companies is also propelling market growth in Asia Pacific, making it a key player in the future of genomics.

Global Genomics Market: Segmentation Analysis

The Global Genomics Market is segmented on the basis of By Technology, By Application, By Product and Services and By Geography.

Genomics Market, By Technology

• Sequencing Technologies
• Microarray Analysis
• PCR
• CRISPR

Based on Technology, the Global Genomics Market is segmented into Sequencing Technologies, Microarray Analysis, PCR, and CRISPR. PCR (polymerase chain reaction), and CRISPR, sequencing technologies are dominating the genomics market due to their widespread application in clinical diagnostics, personalized medicine, and large-scale genomic projects. These technologies, especially next-generation sequencing (NGS), provide comprehensive genetic information with high accuracy. On the other hand, CRISPR is the fastest-growing segment, driven by its revolutionary potential in gene editing, gene therapy, and biotechnology, allowing precise modification of DNA sequences, which is transforming research and therapeutic applications across industries.

Genomics Market, By Application

• Diagnostics
• Drug Discovery and Development
• Research
• Agriculture And Livestock
• Consumer Genomics

Based on Application, the Global Genomics Market is segmented into Diagnostics, Drug Discovery and Development, Research, Agriculture and Livestock, and Consumer Genomics. The Diagnostics segment is dominating the global genomics market, driven by the increasing demand for genetic testing and screening for diseases like cancer and rare genetic disorders. The widespread application of genomic diagnostics in personalized medicine and healthcare systems makes it the leading segment. However, Consumer Genomics is the fastest-growing segment, fueled by the rising popularity of direct-to-consumer genetic testing kits that provide insights into ancestry, health risks, and wellness. The accessibility of these services, along with growing consumer interest in genetic health information, is accelerating its rapid expansion.

Genomics Market, By Products And Services

• Instruments And Equipment
• Consumables
• Software and Services

Based on Product and Services, the Global Genomics Market is segmented into Instruments and Equipment, Consumables, and Software and Services. The Consumables segment dominates due to the recurring demand for reagents, kits, and other supplies required in sequencing and genetic analysis. These consumables are essential for conducting research and diagnostics, driving their consistent use across laboratories, clinics, and research institutions. Meanwhile, the Software and Services segment is the fastest-growing, fueled by the increasing need for advanced data analysis tools to handle large genomic datasets and the rising adoption of cloud-based solutions, bioinformatics, and AI-driven platforms for personalized medicine and research applications.

Genomics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Genomics Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development.

Key Players

• The "Global Genomics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
• llumina, Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation (Beckman Coulter), PerkinElmer, QIAGEN, BGI Group, Macrogen, and Oxford Nanopore Technologies.
• Our
• market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
• Genomics Market Recent Developments:
• In August 2023 Thermo Fisher Scientific completed the acquisition of The Binding Site Group, a leader in specialty diagnostics for blood cancer. This acquisition expands Thermo Fisher's genomics portfolio, enhancing its capabilities in clinical diagnostics and furthering its presence in personalized medicine.
• In July 2023 BGI Group, a leading genomics company, launched its latest high-throughput sequencing technology, "DNBSEQ-T7." This platform offers unprecedented speed and accuracy in genome sequencing, enabling more precise data for use in medical research and clinical applications.
• In June 2023 Roche announced a collaboration with its subsidiary Genentech to expand cancer genomics research. The partnership focuses on utilizing genomic data to develop targeted therapies for cancer patients, aiming to improve personalized treatment plans through comprehensive genetic profiling.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GENOMICS MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL GENOMICS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY

• 5.1 Overview
• 5.2 Sequencing Technologies
• 5.3 Microarray Analysis
• 5.4 PCR
• 5.5 CRISPR

6 GLOBAL GENOMICS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Diagnostics
• 6.3 Drug Discovery and Development
• 6.4 Research
• 6.5 Agriculture And Livestock
• 6.6 Consumer Genomics

7 GLOBAL GENOMICS MARKET, BY PRODUCT AND SERVICES

• 7.1 Overview
• 7.2 Instruments And Equipment
• 7.3 Consumables
• 7.4 Software and Services

8 GLOBAL GENOMICS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL GENOMICS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 llumina
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Thermo Fisher Scientific
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Agilent Technologies
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 , Danaher Corporation (Beckman Coulter)
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 PerkinElmer
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 QIAGEN
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 BGI Group
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Macrogen
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Oxford Nanopore Technologies
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research